TP53 and neoplasm: Seven of the cases had TP53 mutation frequencies above 80%, indicating a homozygous change in all tumour cells when adjusted for the presence of contaminating normal tissue, while heterozygous mutations in TP53 or other known cancer genes in 10 additional cases were present at an average of 49.5%.